Free Trial

SpringWorks Therapeutics (SWTX) Earnings Date, Estimates & Call Transcripts

SpringWorks Therapeutics logo
$47.97 -1.58 (-3.20%)
As of 03:12 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

SpringWorks Therapeutics Latest Earnings Summary

Upcoming Q1
Earnings Date
May. 1Before Market OpensEstimated
Actual EPS
(Feb. 20)
-$1.04 Missed By -$0.38
Consensus EPS
(Feb. 20)
-$0.66

SpringWorks Therapeutics issued Q4 2024 earnings on February 20, 2025, reporting an EPS of -$1.04, which missed analysts' consensus estimates of -$0.66 by $0.38. Quarterly revenue was reported to be $61.55 million, above analyst estimates of $60.53 million. With a trailing EPS of -$3.48, SpringWorks Therapeutics' earnings are expected to grow next year, from ($2.05) to ($0.13) per share.

SWTX Upcoming Earnings

SpringWorks Therapeutics' next earnings date is estimated for Thursday, May 1, 2025, based off prior year's reporting schedules.

Get SpringWorks Therapeutics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on SpringWorks Therapeutics and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

SWTX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

SWTX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.
Remove Ads

SpringWorks Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20252-$0.84-$0.71-$0.78
Q2 20252-$0.78-$0.60-$0.69
Q3 20252-$0.67-$0.50-$0.59
Q4 20252-$0.53-$0.39-$0.46
FY 20258($2.82)($2.20)($2.51)
Remove Ads

SpringWorks Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
5/1/2025
(Estimated)
-------
2/20/2025Q4 2024-$0.66-$1.04 -$0.38-$1.04$60.53M$61.55M
11/12/2024Q3 2024-$0.75-$0.72+$0.03-$0.72$53.28M$49.10M
8/7/2024Q2 2024-$1.12-$0.54+$0.58-$0.54$34.42M$59.73M
5/2/2024Q1 2024-$1.17-$1.18 -$0.01-$1.18$12.07M$21.00M
2/27/2024Q4 2023-$1.24-$1.44 -$0.20-$1.44$1.26M$5.45M
11/2/2023Q3 2023-$1.31-$1.27+$0.04-$1.27--
8/2/2023Q2 2023-$1.26-$1.25+$0.01-$1.25--
5/3/2023Q1 2023-$1.10-$1.18 -$0.08-$1.18--

SpringWorks Therapeutics Earnings - Frequently Asked Questions

SpringWorks Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 1st, 2025 based off last year's report dates. Learn more on SWTX's earnings history.

In the previous quarter, SpringWorks Therapeutics (NASDAQ:SWTX) missed the analysts' consensus estimate of ($0.66) by $0.38 with a reported earnings per share (EPS) of ($1.04). Learn more on analysts' earnings estimate vs. SWTX's actual earnings.

The conference call for SpringWorks Therapeutics's latest earnings report can be listened to online.
Listen to Conference Call

SpringWorks Therapeutics's earnings report can be found in their filing with the SEC.
View SEC filing

SpringWorks Therapeutics (NASDAQ:SWTX) has a recorded annual revenue of $191.59 million.

SpringWorks Therapeutics (NASDAQ:SWTX) has a recorded net income of -$325.10 million. SWTX has generated -$3.48 earnings per share over the last four quarters.

SpringWorks Therapeutics's earnings are expected to grow from ($2.05) per share to ($0.13) per share in the next year.

More Earnings Resources from MarketBeat

Remove Ads


This page (NASDAQ:SWTX) was last updated on 3/10/2025 by MarketBeat.com Staff
From Our Partners